nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—ABCB1—Ethinyl Estradiol—osteoporosis	0.0548	0.203	CbGbCtD
Doxazosin—CYP2C19—Cholecalciferol—osteoporosis	0.0543	0.201	CbGbCtD
Doxazosin—CYP2C19—Estradiol—osteoporosis	0.0438	0.162	CbGbCtD
Doxazosin—CYP2D6—Cholecalciferol—osteoporosis	0.0413	0.153	CbGbCtD
Doxazosin—ABCB1—Conjugated Estrogens—osteoporosis	0.0403	0.149	CbGbCtD
Doxazosin—ABCB1—Estradiol—osteoporosis	0.0353	0.131	CbGbCtD
Doxazosin—Anorexia—Pamidronate—osteoporosis	0.000418	0.000599	CcSEcCtD
Doxazosin—Chest pain—Zoledronate—osteoporosis	0.000418	0.000599	CcSEcCtD
Doxazosin—Arthralgia—Zoledronate—osteoporosis	0.000418	0.000599	CcSEcCtD
Doxazosin—Myalgia—Zoledronate—osteoporosis	0.000418	0.000599	CcSEcCtD
Doxazosin—Palpitations—Conjugated Estrogens—osteoporosis	0.000418	0.000599	CcSEcCtD
Doxazosin—Insomnia—Risedronate—osteoporosis	0.000417	0.000598	CcSEcCtD
Doxazosin—Anxiety—Zoledronate—osteoporosis	0.000416	0.000597	CcSEcCtD
Doxazosin—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000415	0.000595	CcSEcCtD
Doxazosin—Paraesthesia—Risedronate—osteoporosis	0.000414	0.000594	CcSEcCtD
Doxazosin—Pruritus—Estropipate—osteoporosis	0.000413	0.000592	CcSEcCtD
Doxazosin—Discomfort—Zoledronate—osteoporosis	0.000413	0.000592	CcSEcCtD
Doxazosin—Asthenia—Alendronate—osteoporosis	0.000413	0.000591	CcSEcCtD
Doxazosin—Hypersensitivity—Ibandronate—osteoporosis	0.000412	0.000591	CcSEcCtD
Doxazosin—Cough—Conjugated Estrogens—osteoporosis	0.000412	0.000591	CcSEcCtD
Doxazosin—Dyspnoea—Risedronate—osteoporosis	0.000411	0.00059	CcSEcCtD
Doxazosin—Hypotension—Pamidronate—osteoporosis	0.00041	0.000587	CcSEcCtD
Doxazosin—Convulsion—Conjugated Estrogens—osteoporosis	0.00041	0.000587	CcSEcCtD
Doxazosin—Dry mouth—Zoledronate—osteoporosis	0.000409	0.000586	CcSEcCtD
Doxazosin—Fatigue—Ethinyl Estradiol—osteoporosis	0.000408	0.000585	CcSEcCtD
Doxazosin—Pruritus—Alendronate—osteoporosis	0.000407	0.000583	CcSEcCtD
Doxazosin—Dyspepsia—Risedronate—osteoporosis	0.000406	0.000582	CcSEcCtD
Doxazosin—Eye disorder—Estradiol—osteoporosis	0.000406	0.000582	CcSEcCtD
Doxazosin—Tinnitus—Estradiol—osteoporosis	0.000405	0.000581	CcSEcCtD
Doxazosin—Constipation—Ethinyl Estradiol—osteoporosis	0.000405	0.00058	CcSEcCtD
Doxazosin—Confusional state—Zoledronate—osteoporosis	0.000404	0.000579	CcSEcCtD
Doxazosin—Hypersensitivity—Calcitriol—osteoporosis	0.000404	0.000579	CcSEcCtD
Doxazosin—Flushing—Estradiol—osteoporosis	0.000403	0.000578	CcSEcCtD
Doxazosin—Chest pain—Conjugated Estrogens—osteoporosis	0.000402	0.000577	CcSEcCtD
Doxazosin—Arthralgia—Conjugated Estrogens—osteoporosis	0.000402	0.000577	CcSEcCtD
Doxazosin—Myalgia—Conjugated Estrogens—osteoporosis	0.000402	0.000577	CcSEcCtD
Doxazosin—Asthenia—Ibandronate—osteoporosis	0.000402	0.000576	CcSEcCtD
Doxazosin—Anxiety—Conjugated Estrogens—osteoporosis	0.000401	0.000575	CcSEcCtD
Doxazosin—Nausea—Etidronic acid—osteoporosis	0.000401	0.000575	CcSEcCtD
Doxazosin—Oedema—Zoledronate—osteoporosis	0.000401	0.000574	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.0004	0.000573	CcSEcCtD
Doxazosin—Diarrhoea—Estropipate—osteoporosis	0.000399	0.000573	CcSEcCtD
Doxazosin—Infection—Zoledronate—osteoporosis	0.000398	0.00057	CcSEcCtD
Doxazosin—Fatigue—Risedronate—osteoporosis	0.000398	0.00057	CcSEcCtD
Doxazosin—Insomnia—Pamidronate—osteoporosis	0.000397	0.000569	CcSEcCtD
Doxazosin—Pruritus—Ibandronate—osteoporosis	0.000396	0.000568	CcSEcCtD
Doxazosin—Constipation—Risedronate—osteoporosis	0.000395	0.000565	CcSEcCtD
Doxazosin—Pain—Risedronate—osteoporosis	0.000395	0.000565	CcSEcCtD
Doxazosin—Shock—Zoledronate—osteoporosis	0.000394	0.000565	CcSEcCtD
Doxazosin—Paraesthesia—Pamidronate—osteoporosis	0.000394	0.000564	CcSEcCtD
Doxazosin—Diarrhoea—Alendronate—osteoporosis	0.000393	0.000564	CcSEcCtD
Doxazosin—Asthenia—Calcitriol—osteoporosis	0.000393	0.000564	CcSEcCtD
Doxazosin—Thrombocytopenia—Zoledronate—osteoporosis	0.000392	0.000562	CcSEcCtD
Doxazosin—Dyspnoea—Pamidronate—osteoporosis	0.000391	0.00056	CcSEcCtD
Doxazosin—Tachycardia—Zoledronate—osteoporosis	0.000391	0.00056	CcSEcCtD
Doxazosin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00039	0.000559	CcSEcCtD
Doxazosin—Chills—Estradiol—osteoporosis	0.00039	0.000559	CcSEcCtD
Doxazosin—Somnolence—Pamidronate—osteoporosis	0.00039	0.000559	CcSEcCtD
Doxazosin—Skin disorder—Zoledronate—osteoporosis	0.000389	0.000558	CcSEcCtD
Doxazosin—Pruritus—Calcitriol—osteoporosis	0.000388	0.000556	CcSEcCtD
Doxazosin—Hyperhidrosis—Zoledronate—osteoporosis	0.000387	0.000555	CcSEcCtD
Doxazosin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000387	0.000555	CcSEcCtD
Doxazosin—Diarrhoea—Raloxifene—osteoporosis	0.000387	0.000555	CcSEcCtD
Doxazosin—Dyspepsia—Pamidronate—osteoporosis	0.000386	0.000553	CcSEcCtD
Doxazosin—Dizziness—Estropipate—osteoporosis	0.000386	0.000553	CcSEcCtD
Doxazosin—Oedema—Conjugated Estrogens—osteoporosis	0.000386	0.000553	CcSEcCtD
Doxazosin—Alopecia—Estradiol—osteoporosis	0.000384	0.00055	CcSEcCtD
Doxazosin—Infection—Conjugated Estrogens—osteoporosis	0.000383	0.000549	CcSEcCtD
Doxazosin—Diarrhoea—Ibandronate—osteoporosis	0.000383	0.000549	CcSEcCtD
Doxazosin—Anorexia—Zoledronate—osteoporosis	0.000382	0.000547	CcSEcCtD
Doxazosin—Decreased appetite—Pamidronate—osteoporosis	0.000381	0.000546	CcSEcCtD
Doxazosin—Mental disorder—Estradiol—osteoporosis	0.000381	0.000546	CcSEcCtD
Doxazosin—Dizziness—Alendronate—osteoporosis	0.00038	0.000545	CcSEcCtD
Doxazosin—Shock—Conjugated Estrogens—osteoporosis	0.00038	0.000544	CcSEcCtD
Doxazosin—Malnutrition—Estradiol—osteoporosis	0.000378	0.000542	CcSEcCtD
Doxazosin—Fatigue—Pamidronate—osteoporosis	0.000378	0.000542	CcSEcCtD
Doxazosin—Gastrointestinal pain—Risedronate—osteoporosis	0.000377	0.000541	CcSEcCtD
Doxazosin—Tachycardia—Conjugated Estrogens—osteoporosis	0.000377	0.00054	CcSEcCtD
Doxazosin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000376	0.000539	CcSEcCtD
Doxazosin—Pain—Pamidronate—osteoporosis	0.000375	0.000538	CcSEcCtD
Doxazosin—Constipation—Pamidronate—osteoporosis	0.000375	0.000538	CcSEcCtD
Doxazosin—Diarrhoea—Calcitriol—osteoporosis	0.000375	0.000537	CcSEcCtD
Doxazosin—Skin disorder—Conjugated Estrogens—osteoporosis	0.000375	0.000537	CcSEcCtD
Doxazosin—Hypotension—Zoledronate—osteoporosis	0.000374	0.000537	CcSEcCtD
Doxazosin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000374	0.000536	CcSEcCtD
Doxazosin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000374	0.000536	CcSEcCtD
Doxazosin—Dizziness—Raloxifene—osteoporosis	0.000374	0.000536	CcSEcCtD
Doxazosin—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000373	0.000534	CcSEcCtD
Doxazosin—Flatulence—Estradiol—osteoporosis	0.000373	0.000534	CcSEcCtD
Doxazosin—Tension—Estradiol—osteoporosis	0.000371	0.000532	CcSEcCtD
Doxazosin—Vomiting—Estropipate—osteoporosis	0.000371	0.000532	CcSEcCtD
Doxazosin—Dysgeusia—Estradiol—osteoporosis	0.00037	0.000531	CcSEcCtD
Doxazosin—Dizziness—Ibandronate—osteoporosis	0.00037	0.000531	CcSEcCtD
Doxazosin—Rash—Estropipate—osteoporosis	0.000368	0.000528	CcSEcCtD
Doxazosin—Dermatitis—Estropipate—osteoporosis	0.000368	0.000527	CcSEcCtD
Doxazosin—Anorexia—Conjugated Estrogens—osteoporosis	0.000368	0.000527	CcSEcCtD
Doxazosin—Nervousness—Estradiol—osteoporosis	0.000367	0.000527	CcSEcCtD
Doxazosin—Urticaria—Risedronate—osteoporosis	0.000367	0.000525	CcSEcCtD
Doxazosin—Back pain—Estradiol—osteoporosis	0.000366	0.000524	CcSEcCtD
Doxazosin—Headache—Estropipate—osteoporosis	0.000366	0.000524	CcSEcCtD
Doxazosin—Vomiting—Alendronate—osteoporosis	0.000366	0.000524	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000365	0.000523	CcSEcCtD
Doxazosin—Abdominal pain—Risedronate—osteoporosis	0.000365	0.000523	CcSEcCtD
Doxazosin—Body temperature increased—Risedronate—osteoporosis	0.000365	0.000523	CcSEcCtD
Doxazosin—Muscle spasms—Estradiol—osteoporosis	0.000364	0.000521	CcSEcCtD
Doxazosin—Rash—Alendronate—osteoporosis	0.000363	0.00052	CcSEcCtD
Doxazosin—Insomnia—Zoledronate—osteoporosis	0.000362	0.000519	CcSEcCtD
Doxazosin—Dermatitis—Alendronate—osteoporosis	0.000362	0.000519	CcSEcCtD
Doxazosin—Feeling abnormal—Pamidronate—osteoporosis	0.000361	0.000518	CcSEcCtD
Doxazosin—Hypotension—Conjugated Estrogens—osteoporosis	0.00036	0.000517	CcSEcCtD
Doxazosin—Headache—Alendronate—osteoporosis	0.00036	0.000516	CcSEcCtD
Doxazosin—Paraesthesia—Zoledronate—osteoporosis	0.00036	0.000516	CcSEcCtD
Doxazosin—Vomiting—Raloxifene—osteoporosis	0.00036	0.000515	CcSEcCtD
Doxazosin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000359	0.000514	CcSEcCtD
Doxazosin—Dyspnoea—Zoledronate—osteoporosis	0.000357	0.000512	CcSEcCtD
Doxazosin—Rash—Raloxifene—osteoporosis	0.000357	0.000511	CcSEcCtD
Doxazosin—Dermatitis—Raloxifene—osteoporosis	0.000356	0.000511	CcSEcCtD
Doxazosin—Somnolence—Zoledronate—osteoporosis	0.000356	0.00051	CcSEcCtD
Doxazosin—Vomiting—Ibandronate—osteoporosis	0.000356	0.00051	CcSEcCtD
Doxazosin—Tremor—Estradiol—osteoporosis	0.000354	0.000508	CcSEcCtD
Doxazosin—Headache—Raloxifene—osteoporosis	0.000354	0.000508	CcSEcCtD
Doxazosin—Rash—Ibandronate—osteoporosis	0.000353	0.000506	CcSEcCtD
Doxazosin—Dermatitis—Ibandronate—osteoporosis	0.000353	0.000505	CcSEcCtD
Doxazosin—Dyspepsia—Zoledronate—osteoporosis	0.000353	0.000505	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000351	0.000504	CcSEcCtD
Doxazosin—Ill-defined disorder—Estradiol—osteoporosis	0.000351	0.000503	CcSEcCtD
Doxazosin—Headache—Ibandronate—osteoporosis	0.000351	0.000503	CcSEcCtD
Doxazosin—Insomnia—Conjugated Estrogens—osteoporosis	0.000349	0.0005	CcSEcCtD
Doxazosin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000349	0.0005	CcSEcCtD
Doxazosin—Vomiting—Calcitriol—osteoporosis	0.000348	0.000499	CcSEcCtD
Doxazosin—Decreased appetite—Zoledronate—osteoporosis	0.000348	0.000499	CcSEcCtD
Doxazosin—Agitation—Estradiol—osteoporosis	0.000348	0.000498	CcSEcCtD
Doxazosin—Nausea—Estropipate—osteoporosis	0.000347	0.000497	CcSEcCtD
Doxazosin—Abdominal pain—Pamidronate—osteoporosis	0.000347	0.000497	CcSEcCtD
Doxazosin—Body temperature increased—Pamidronate—osteoporosis	0.000347	0.000497	CcSEcCtD
Doxazosin—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000346	0.000496	CcSEcCtD
Doxazosin—Rash—Calcitriol—osteoporosis	0.000346	0.000495	CcSEcCtD
Doxazosin—Fatigue—Zoledronate—osteoporosis	0.000345	0.000495	CcSEcCtD
Doxazosin—Dermatitis—Calcitriol—osteoporosis	0.000345	0.000495	CcSEcCtD
Doxazosin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000344	0.000493	CcSEcCtD
Doxazosin—Headache—Calcitriol—osteoporosis	0.000343	0.000492	CcSEcCtD
Doxazosin—Somnolence—Conjugated Estrogens—osteoporosis	0.000343	0.000492	CcSEcCtD
Doxazosin—Pain—Zoledronate—osteoporosis	0.000343	0.000491	CcSEcCtD
Doxazosin—Constipation—Zoledronate—osteoporosis	0.000343	0.000491	CcSEcCtD
Doxazosin—Nausea—Alendronate—osteoporosis	0.000342	0.00049	CcSEcCtD
Doxazosin—Malaise—Estradiol—osteoporosis	0.000341	0.000489	CcSEcCtD
Doxazosin—Hypersensitivity—Risedronate—osteoporosis	0.00034	0.000487	CcSEcCtD
Doxazosin—Vertigo—Estradiol—osteoporosis	0.00034	0.000487	CcSEcCtD
Doxazosin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00034	0.000487	CcSEcCtD
Doxazosin—Asthenia—Ethinyl Estradiol—osteoporosis	0.00034	0.000487	CcSEcCtD
Doxazosin—Syncope—Estradiol—osteoporosis	0.000339	0.000486	CcSEcCtD
Doxazosin—Nausea—Raloxifene—osteoporosis	0.000336	0.000481	CcSEcCtD
Doxazosin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000335	0.000481	CcSEcCtD
Doxazosin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000335	0.00048	CcSEcCtD
Doxazosin—Palpitations—Estradiol—osteoporosis	0.000334	0.000479	CcSEcCtD
Doxazosin—Fatigue—Conjugated Estrogens—osteoporosis	0.000333	0.000477	CcSEcCtD
Doxazosin—Nausea—Ibandronate—osteoporosis	0.000333	0.000477	CcSEcCtD
Doxazosin—Loss of consciousness—Estradiol—osteoporosis	0.000333	0.000477	CcSEcCtD
Doxazosin—Asthenia—Risedronate—osteoporosis	0.000331	0.000474	CcSEcCtD
Doxazosin—Feeling abnormal—Zoledronate—osteoporosis	0.00033	0.000473	CcSEcCtD
Doxazosin—Cough—Estradiol—osteoporosis	0.00033	0.000473	CcSEcCtD
Doxazosin—Pain—Conjugated Estrogens—osteoporosis	0.00033	0.000473	CcSEcCtD
Doxazosin—Constipation—Conjugated Estrogens—osteoporosis	0.00033	0.000473	CcSEcCtD
Doxazosin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000328	0.00047	CcSEcCtD
Doxazosin—Hypertension—Estradiol—osteoporosis	0.000327	0.000468	CcSEcCtD
Doxazosin—Pruritus—Risedronate—osteoporosis	0.000326	0.000468	CcSEcCtD
Doxazosin—Nausea—Calcitriol—osteoporosis	0.000326	0.000467	CcSEcCtD
Doxazosin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000324	0.000464	CcSEcCtD
Doxazosin—Hypersensitivity—Pamidronate—osteoporosis	0.000323	0.000463	CcSEcCtD
Doxazosin—Myalgia—Estradiol—osteoporosis	0.000322	0.000462	CcSEcCtD
Doxazosin—Arthralgia—Estradiol—osteoporosis	0.000322	0.000462	CcSEcCtD
Doxazosin—Chest pain—Estradiol—osteoporosis	0.000322	0.000462	CcSEcCtD
Doxazosin—Anxiety—Estradiol—osteoporosis	0.000321	0.00046	CcSEcCtD
Doxazosin—Urticaria—Zoledronate—osteoporosis	0.000318	0.000456	CcSEcCtD
Doxazosin—Discomfort—Estradiol—osteoporosis	0.000318	0.000456	CcSEcCtD
Doxazosin—Body temperature increased—Zoledronate—osteoporosis	0.000317	0.000454	CcSEcCtD
Doxazosin—Abdominal pain—Zoledronate—osteoporosis	0.000317	0.000454	CcSEcCtD
Doxazosin—Diarrhoea—Risedronate—osteoporosis	0.000316	0.000452	CcSEcCtD
Doxazosin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000315	0.000452	CcSEcCtD
Doxazosin—Dry mouth—Estradiol—osteoporosis	0.000315	0.000451	CcSEcCtD
Doxazosin—Asthenia—Pamidronate—osteoporosis	0.000315	0.000451	CcSEcCtD
Doxazosin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000313	0.000449	CcSEcCtD
Doxazosin—Confusional state—Estradiol—osteoporosis	0.000311	0.000446	CcSEcCtD
Doxazosin—Pruritus—Pamidronate—osteoporosis	0.00031	0.000445	CcSEcCtD
Doxazosin—Oedema—Estradiol—osteoporosis	0.000309	0.000443	CcSEcCtD
Doxazosin—Infection—Estradiol—osteoporosis	0.000307	0.00044	CcSEcCtD
Doxazosin—Urticaria—Conjugated Estrogens—osteoporosis	0.000306	0.000439	CcSEcCtD
Doxazosin—Dizziness—Risedronate—osteoporosis	0.000305	0.000437	CcSEcCtD
Doxazosin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000305	0.000437	CcSEcCtD
Doxazosin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000305	0.000437	CcSEcCtD
Doxazosin—Shock—Estradiol—osteoporosis	0.000304	0.000435	CcSEcCtD
Doxazosin—Tachycardia—Estradiol—osteoporosis	0.000301	0.000432	CcSEcCtD
Doxazosin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000301	0.000431	CcSEcCtD
Doxazosin—Diarrhoea—Pamidronate—osteoporosis	0.0003	0.00043	CcSEcCtD
Doxazosin—Skin disorder—Estradiol—osteoporosis	0.0003	0.00043	CcSEcCtD
Doxazosin—Hyperhidrosis—Estradiol—osteoporosis	0.000298	0.000428	CcSEcCtD
Doxazosin—Rash—Ethinyl Estradiol—osteoporosis	0.000298	0.000428	CcSEcCtD
Doxazosin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000298	0.000427	CcSEcCtD
Doxazosin—Headache—Ethinyl Estradiol—osteoporosis	0.000296	0.000425	CcSEcCtD
Doxazosin—Hypersensitivity—Zoledronate—osteoporosis	0.000295	0.000423	CcSEcCtD
Doxazosin—Vomiting—Risedronate—osteoporosis	0.000293	0.00042	CcSEcCtD
Doxazosin—Rash—Risedronate—osteoporosis	0.000291	0.000417	CcSEcCtD
Doxazosin—Dermatitis—Risedronate—osteoporosis	0.000291	0.000417	CcSEcCtD
Doxazosin—Dizziness—Pamidronate—osteoporosis	0.00029	0.000416	CcSEcCtD
Doxazosin—Headache—Risedronate—osteoporosis	0.000289	0.000414	CcSEcCtD
Doxazosin—Asthenia—Zoledronate—osteoporosis	0.000287	0.000412	CcSEcCtD
Doxazosin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000284	0.000407	CcSEcCtD
Doxazosin—Pruritus—Zoledronate—osteoporosis	0.000283	0.000406	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000281	0.000403	CcSEcCtD
Doxazosin—Nausea—Ethinyl Estradiol—osteoporosis	0.000281	0.000403	CcSEcCtD
Doxazosin—Insomnia—Estradiol—osteoporosis	0.000279	0.0004	CcSEcCtD
Doxazosin—Vomiting—Pamidronate—osteoporosis	0.000279	0.0004	CcSEcCtD
Doxazosin—Paraesthesia—Estradiol—osteoporosis	0.000277	0.000397	CcSEcCtD
Doxazosin—Asthenia—Conjugated Estrogens—osteoporosis	0.000277	0.000397	CcSEcCtD
Doxazosin—Rash—Pamidronate—osteoporosis	0.000277	0.000396	CcSEcCtD
Doxazosin—Dermatitis—Pamidronate—osteoporosis	0.000276	0.000396	CcSEcCtD
Doxazosin—Dyspnoea—Estradiol—osteoporosis	0.000275	0.000395	CcSEcCtD
Doxazosin—Headache—Pamidronate—osteoporosis	0.000275	0.000394	CcSEcCtD
Doxazosin—Somnolence—Estradiol—osteoporosis	0.000274	0.000393	CcSEcCtD
Doxazosin—Diarrhoea—Zoledronate—osteoporosis	0.000274	0.000393	CcSEcCtD
Doxazosin—Nausea—Risedronate—osteoporosis	0.000274	0.000393	CcSEcCtD
Doxazosin—Pruritus—Conjugated Estrogens—osteoporosis	0.000273	0.000391	CcSEcCtD
Doxazosin—Dyspepsia—Estradiol—osteoporosis	0.000272	0.00039	CcSEcCtD
Doxazosin—Decreased appetite—Estradiol—osteoporosis	0.000268	0.000385	CcSEcCtD
Doxazosin—Fatigue—Estradiol—osteoporosis	0.000266	0.000382	CcSEcCtD
Doxazosin—Dizziness—Zoledronate—osteoporosis	0.000265	0.00038	CcSEcCtD
Doxazosin—Pain—Estradiol—osteoporosis	0.000264	0.000378	CcSEcCtD
Doxazosin—Constipation—Estradiol—osteoporosis	0.000264	0.000378	CcSEcCtD
Doxazosin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000264	0.000378	CcSEcCtD
Doxazosin—Nausea—Pamidronate—osteoporosis	0.000261	0.000373	CcSEcCtD
Doxazosin—Dizziness—Conjugated Estrogens—osteoporosis	0.000255	0.000366	CcSEcCtD
Doxazosin—Vomiting—Zoledronate—osteoporosis	0.000255	0.000365	CcSEcCtD
Doxazosin—Feeling abnormal—Estradiol—osteoporosis	0.000254	0.000365	CcSEcCtD
Doxazosin—Rash—Zoledronate—osteoporosis	0.000253	0.000362	CcSEcCtD
Doxazosin—Gastrointestinal pain—Estradiol—osteoporosis	0.000252	0.000362	CcSEcCtD
Doxazosin—Dermatitis—Zoledronate—osteoporosis	0.000252	0.000362	CcSEcCtD
Doxazosin—Headache—Zoledronate—osteoporosis	0.000251	0.00036	CcSEcCtD
Doxazosin—Vomiting—Conjugated Estrogens—osteoporosis	0.000245	0.000352	CcSEcCtD
Doxazosin—Urticaria—Estradiol—osteoporosis	0.000245	0.000352	CcSEcCtD
Doxazosin—Abdominal pain—Estradiol—osteoporosis	0.000244	0.00035	CcSEcCtD
Doxazosin—Body temperature increased—Estradiol—osteoporosis	0.000244	0.00035	CcSEcCtD
Doxazosin—Rash—Conjugated Estrogens—osteoporosis	0.000243	0.000349	CcSEcCtD
Doxazosin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000243	0.000348	CcSEcCtD
Doxazosin—Headache—Conjugated Estrogens—osteoporosis	0.000242	0.000346	CcSEcCtD
Doxazosin—Nausea—Zoledronate—osteoporosis	0.000238	0.000341	CcSEcCtD
Doxazosin—Nausea—Conjugated Estrogens—osteoporosis	0.000229	0.000328	CcSEcCtD
Doxazosin—Hypersensitivity—Estradiol—osteoporosis	0.000227	0.000326	CcSEcCtD
Doxazosin—Asthenia—Estradiol—osteoporosis	0.000222	0.000317	CcSEcCtD
Doxazosin—Pruritus—Estradiol—osteoporosis	0.000218	0.000313	CcSEcCtD
Doxazosin—Diarrhoea—Estradiol—osteoporosis	0.000211	0.000303	CcSEcCtD
Doxazosin—Dizziness—Estradiol—osteoporosis	0.000204	0.000293	CcSEcCtD
Doxazosin—Vomiting—Estradiol—osteoporosis	0.000196	0.000281	CcSEcCtD
Doxazosin—Rash—Estradiol—osteoporosis	0.000195	0.000279	CcSEcCtD
Doxazosin—Dermatitis—Estradiol—osteoporosis	0.000194	0.000279	CcSEcCtD
Doxazosin—Headache—Estradiol—osteoporosis	0.000193	0.000277	CcSEcCtD
Doxazosin—Nausea—Estradiol—osteoporosis	0.000183	0.000263	CcSEcCtD
Doxazosin—ABCB1—Metabolism—PGLS—osteoporosis	3.24e-05	0.001	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GPD2—osteoporosis	3.24e-05	0.001	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CNR2—osteoporosis	3.24e-05	0.001	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—CALCA—osteoporosis	3.23e-05	0.000999	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PKM—osteoporosis	3.22e-05	0.000995	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—FDPS—osteoporosis	3.22e-05	0.000995	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.2e-05	0.00099	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MGLL—osteoporosis	3.19e-05	0.000987	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—LRP5—osteoporosis	3.12e-05	0.000963	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GPD2—osteoporosis	3.05e-05	0.000943	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PGLS—osteoporosis	3.05e-05	0.000943	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—WNT1—osteoporosis	3.04e-05	0.000941	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ATIC—osteoporosis	3.03e-05	0.000938	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PNP—osteoporosis	3.03e-05	0.000938	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PTHLH—osteoporosis	3.03e-05	0.000937	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—IDH2—osteoporosis	3.02e-05	0.000933	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—POMC—osteoporosis	2.99e-05	0.000925	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—LRP6—osteoporosis	2.98e-05	0.000922	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MGLL—osteoporosis	2.97e-05	0.000917	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PTHLH—osteoporosis	2.96e-05	0.000916	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PNP—osteoporosis	2.96e-05	0.000915	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ATIC—osteoporosis	2.96e-05	0.000915	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—P4HB—osteoporosis	2.94e-05	0.00091	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CALCA—osteoporosis	2.93e-05	0.000907	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LRP5—osteoporosis	2.89e-05	0.000895	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CALCA—osteoporosis	2.87e-05	0.000888	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PTH—osteoporosis	2.86e-05	0.000885	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CYP27A1—osteoporosis	2.84e-05	0.000877	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TLN1—osteoporosis	2.83e-05	0.000876	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RAP1A—osteoporosis	2.81e-05	0.00087	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CNR2—osteoporosis	2.79e-05	0.000863	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ATIC—osteoporosis	2.79e-05	0.000863	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PNP—osteoporosis	2.79e-05	0.000863	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.78e-05	0.000859	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—ADCY5—osteoporosis	2.77e-05	0.000856	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LRP6—osteoporosis	2.77e-05	0.000856	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ACP5—osteoporosis	2.76e-05	0.000853	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PTHLH—osteoporosis	2.75e-05	0.000851	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NFATC1—osteoporosis	2.74e-05	0.000849	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—DKK1—osteoporosis	2.72e-05	0.000842	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CALCA—osteoporosis	2.67e-05	0.000825	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—POMC—osteoporosis	2.66e-05	0.000822	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—WNT1—osteoporosis	2.62e-05	0.000811	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CALCA—osteoporosis	2.61e-05	0.000806	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CA2—osteoporosis	2.58e-05	0.000797	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—OXCT1—osteoporosis	2.58e-05	0.000797	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—TPI1—osteoporosis	2.56e-05	0.000793	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—FGA—osteoporosis	2.55e-05	0.000789	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CA2—osteoporosis	2.52e-05	0.000778	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—OXCT1—osteoporosis	2.52e-05	0.000778	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TLN1—osteoporosis	2.52e-05	0.000778	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—ADCY5—osteoporosis	2.51e-05	0.000778	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—MGLL—osteoporosis	2.51e-05	0.000777	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	2.47e-05	0.000764	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—POMC—osteoporosis	2.47e-05	0.000764	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—MGLL—osteoporosis	2.45e-05	0.000758	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—P4HB—osteoporosis	2.44e-05	0.000755	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CALCA—osteoporosis	2.42e-05	0.000749	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—P4HB—osteoporosis	2.41e-05	0.000746	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PTH—osteoporosis	2.38e-05	0.000735	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PTHLH—osteoporosis	2.37e-05	0.000734	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—BMP2—osteoporosis	2.37e-05	0.000734	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—OXCT1—osteoporosis	2.37e-05	0.000733	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CA2—osteoporosis	2.37e-05	0.000733	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.37e-05	0.000733	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GAPDH—osteoporosis	2.37e-05	0.000732	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TLN1—osteoporosis	2.34e-05	0.000723	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RAP1A—osteoporosis	2.34e-05	0.000722	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—FGB—osteoporosis	2.32e-05	0.000718	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CNR2—osteoporosis	2.32e-05	0.000716	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—MGLL—osteoporosis	2.31e-05	0.000715	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.31e-05	0.000713	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—RAP1A—osteoporosis	2.3e-05	0.000713	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—ADCY5—osteoporosis	2.3e-05	0.000711	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NFATC1—osteoporosis	2.28e-05	0.000705	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—DKK1—osteoporosis	2.26e-05	0.000699	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PSMA2—osteoporosis	2.24e-05	0.000693	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PSMA5—osteoporosis	2.24e-05	0.000693	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—WNT1—osteoporosis	2.18e-05	0.000673	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—P4HB—osteoporosis	2.17e-05	0.000671	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—IDH2—osteoporosis	2.14e-05	0.000661	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—IGF1—osteoporosis	2.12e-05	0.000657	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FGA—osteoporosis	2.12e-05	0.000655	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PTH—osteoporosis	2.11e-05	0.000653	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CALCA—osteoporosis	2.09e-05	0.000646	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—ADCY5—osteoporosis	2.09e-05	0.000646	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—IDH2—osteoporosis	2.09e-05	0.000645	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RAP1A—osteoporosis	2.07e-05	0.000641	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CNR2—osteoporosis	2.06e-05	0.000636	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.05e-05	0.000633	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—ADCY5—osteoporosis	2.04e-05	0.000631	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—POMC—osteoporosis	2.04e-05	0.00063	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NFATC1—osteoporosis	2.02e-05	0.000626	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—P4HB—osteoporosis	2.02e-05	0.000623	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.01e-05	0.000621	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—DKK1—osteoporosis	2.01e-05	0.000621	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PTHLH—osteoporosis	1.97e-05	0.000609	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—BMP2—osteoporosis	1.97e-05	0.000609	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—IDH2—osteoporosis	1.97e-05	0.000608	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTH—osteoporosis	1.96e-05	0.000606	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP27A1—osteoporosis	1.96e-05	0.000606	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ACP5—osteoporosis	1.95e-05	0.000604	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—WNT1—osteoporosis	1.93e-05	0.000598	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.93e-05	0.000597	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	1.93e-05	0.000596	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FGB—osteoporosis	1.93e-05	0.000596	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.92e-05	0.000595	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.92e-05	0.000594	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CNR2—osteoporosis	1.91e-05	0.000591	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ACP5—osteoporosis	1.91e-05	0.00059	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	1.9e-05	0.000587	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—KL—osteoporosis	1.9e-05	0.000587	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FGA—osteoporosis	1.88e-05	0.000582	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	1.88e-05	0.000581	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—DKK1—osteoporosis	1.87e-05	0.000577	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ENO1—osteoporosis	1.86e-05	0.000576	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PSMA5—osteoporosis	1.86e-05	0.000575	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PSMA2—osteoporosis	1.86e-05	0.000575	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—ADCY5—osteoporosis	1.85e-05	0.000573	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—POMC—osteoporosis	1.85e-05	0.000572	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.85e-05	0.000571	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PSMA5—osteoporosis	1.84e-05	0.000568	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PSMA2—osteoporosis	1.84e-05	0.000568	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—TPI1—osteoporosis	1.82e-05	0.000562	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL6R—osteoporosis	1.8e-05	0.000558	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ACP5—osteoporosis	1.8e-05	0.000556	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—WNT1—osteoporosis	1.8e-05	0.000556	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.8e-05	0.000556	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.79e-05	0.000554	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—TPI1—osteoporosis	1.77e-05	0.000548	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PTHLH—osteoporosis	1.75e-05	0.000541	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—BMP2—osteoporosis	1.75e-05	0.000541	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FGA—osteoporosis	1.75e-05	0.000541	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CALCA—osteoporosis	1.73e-05	0.000536	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	1.72e-05	0.000533	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FGB—osteoporosis	1.71e-05	0.000529	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—P4HB—osteoporosis	1.71e-05	0.000528	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—POMC—osteoporosis	1.69e-05	0.000523	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GAPDH—osteoporosis	1.68e-05	0.000519	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—TPI1—osteoporosis	1.67e-05	0.000517	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—P4HB—osteoporosis	1.67e-05	0.000516	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	1.65e-05	0.000511	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	1.65e-05	0.000511	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GAPDH—osteoporosis	1.64e-05	0.000506	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—RAP1A—osteoporosis	1.63e-05	0.000505	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	1.62e-05	0.000503	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—BMP2—osteoporosis	1.62e-05	0.000503	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—RAP1A—osteoporosis	1.59e-05	0.000493	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FGB—osteoporosis	1.59e-05	0.000492	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KL—osteoporosis	1.57e-05	0.000487	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—P4HB—osteoporosis	1.57e-05	0.000486	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GAPDH—osteoporosis	1.54e-05	0.000477	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CALCA—osteoporosis	1.54e-05	0.000476	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—POMC—osteoporosis	1.54e-05	0.000475	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	1.54e-05	0.000475	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	1.54e-05	0.000475	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—RAP1A—osteoporosis	1.5e-05	0.000464	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	1.5e-05	0.000464	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	1.5e-05	0.000463	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CYP19A1—osteoporosis	1.49e-05	0.000461	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ADCY5—osteoporosis	1.49e-05	0.000459	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SPP1—osteoporosis	1.44e-05	0.000444	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CALCA—osteoporosis	1.43e-05	0.000442	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.42e-05	0.00044	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KL—osteoporosis	1.4e-05	0.000432	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	1.4e-05	0.000432	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—POMC—osteoporosis	1.36e-05	0.000422	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	1.33e-05	0.000411	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ENO1—osteoporosis	1.32e-05	0.000408	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PSMA2—osteoporosis	1.3e-05	0.000402	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PSMA5—osteoporosis	1.3e-05	0.000402	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IRS2—osteoporosis	1.3e-05	0.000402	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KL—osteoporosis	1.3e-05	0.000402	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ENO1—osteoporosis	1.29e-05	0.000398	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.27e-05	0.000394	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—LEP—osteoporosis	1.27e-05	0.000393	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PSMA2—osteoporosis	1.27e-05	0.000393	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PSMA5—osteoporosis	1.27e-05	0.000393	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.27e-05	0.000392	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.24e-05	0.000382	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	1.23e-05	0.000381	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ADCY5—osteoporosis	1.22e-05	0.000376	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ESR1—osteoporosis	1.21e-05	0.000376	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ENO1—osteoporosis	1.21e-05	0.000375	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GPX1—osteoporosis	1.21e-05	0.000375	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PSMA2—osteoporosis	1.2e-05	0.00037	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PSMA5—osteoporosis	1.2e-05	0.00037	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SPP1—osteoporosis	1.19e-05	0.000369	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IRS1—osteoporosis	1.13e-05	0.000351	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—MTHFR—osteoporosis	1.12e-05	0.000346	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	1.1e-05	0.000339	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—POMC—osteoporosis	1.09e-05	0.000338	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IRS2—osteoporosis	1.08e-05	0.000334	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL6R—osteoporosis	1.07e-05	0.00033	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.06e-05	0.000328	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—LEP—osteoporosis	1.06e-05	0.000326	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.06e-05	0.000326	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IGF1—osteoporosis	1.05e-05	0.000325	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP19A1—osteoporosis	1.03e-05	0.000319	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.02e-05	0.000315	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ESR1—osteoporosis	1.01e-05	0.000312	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SPP1—osteoporosis	9.85e-06	0.000304	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP19A1—osteoporosis	9.71e-06	0.0003	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IRS2—osteoporosis	9.58e-06	0.000296	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IRS1—osteoporosis	9.42e-06	0.000291	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—LEP—osteoporosis	9.38e-06	0.00029	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—POMC—osteoporosis	9.07e-06	0.00028	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ESR1—osteoporosis	8.95e-06	0.000277	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—POMC—osteoporosis	8.95e-06	0.000277	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IRS2—osteoporosis	8.9e-06	0.000275	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6R—osteoporosis	8.85e-06	0.000274	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IGF1—osteoporosis	8.72e-06	0.00027	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LEP—osteoporosis	8.71e-06	0.000269	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ADCY5—osteoporosis	8.62e-06	0.000267	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GPX1—osteoporosis	8.59e-06	0.000266	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ADCY5—osteoporosis	8.42e-06	0.00026	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GPX1—osteoporosis	8.39e-06	0.000259	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IRS1—osteoporosis	8.37e-06	0.000259	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ESR1—osteoporosis	8.32e-06	0.000257	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—POMC—osteoporosis	8.06e-06	0.000249	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL6—osteoporosis	8.04e-06	0.000249	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ADCY5—osteoporosis	7.93e-06	0.000245	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—MTHFR—osteoporosis	7.93e-06	0.000245	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GPX1—osteoporosis	7.9e-06	0.000244	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6R—osteoporosis	7.86e-06	0.000243	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IRS1—osteoporosis	7.77e-06	0.00024	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF1—osteoporosis	7.75e-06	0.00024	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—MTHFR—osteoporosis	7.74e-06	0.000239	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—POMC—osteoporosis	7.48e-06	0.000231	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6R—osteoporosis	7.3e-06	0.000226	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—MTHFR—osteoporosis	7.29e-06	0.000226	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF1—osteoporosis	7.2e-06	0.000223	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL6—osteoporosis	6.67e-06	0.000206	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—POMC—osteoporosis	6.34e-06	0.000196	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MYC—osteoporosis	6.32e-06	0.000195	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	6.3e-06	0.000195	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—POMC—osteoporosis	6.19e-06	0.000191	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL6—osteoporosis	5.93e-06	0.000183	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—POMC—osteoporosis	5.83e-06	0.00018	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL6—osteoporosis	5.51e-06	0.00017	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MYC—osteoporosis	5.24e-06	0.000162	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	5.23e-06	0.000162	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL6—osteoporosis	4.75e-06	0.000147	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MYC—osteoporosis	4.66e-06	0.000144	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	4.65e-06	0.000144	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MYC—osteoporosis	4.33e-06	0.000134	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	4.32e-06	0.000133	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6—osteoporosis	3.94e-06	0.000122	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6—osteoporosis	3.5e-06	0.000108	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6—osteoporosis	3.25e-06	0.000101	CbGpPWpGaD
